JulienHogan France

Wcn26 Post edited Speaker Card

28 March 2026

Time

Session

3:45 p.m.

4:45 p.m.

HIT! High Impact Clinical Trials 1

Sydney Tang Chair Hong Kong, China

Remodel Overview - Framework And Key Outcomes

PetterBjornstad Speaker United States
Semaglutide Improves Kidney Outcomes Regardless Of SGLT2i Use In People With Chronic Kidney Disease And Type 2 Diabetes: Post-hoc Analysis The Remodel Trial

DavidCherney Speaker Canada
ACHIEVE
B-cell Targeted Therapy for Idiopathic Nephrotic Syndrome: Results of the Phase III Global Multicenter Inshore Trial Evaluating Efficacy and Safety of Obinutuzumab vs Mycophenolate Mofetil

JulienHogan Speaker France

Main Hall